Find similar content

Source channel @githubtrending · Post #15417 · Jan 16

#shell OpenCode now supports Claude Max/Pro subscriptions through the `opencode-anthropic-auth` plugin, allowing you to use your Claude subscription with both Claude Code and OpenCode in your terminal. This integration works with Gentleman.Dots, a complete development environment configuration that includes Neovim with AI assistants, multiple shells (Fish, Zsh, Nushell), terminal multiplexers (Tmux, Zellij), and various terminal emulators. You can install it via Homebrew or direct download across macOS, Linux, and Android platforms. The setup includes an interactive TUI installer that automatically configures your preferred tools, plus a Vim Mastery Trainer for learning editor shortcuts through progressive lessons and boss fights. This gives you a fully integrated AI-powered coding environment optimized for terminal-based development workflows. https://github.com/Gentleman-Programming/Gentleman.Dots

Hashtags

#shell

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment